Brow Ptosis After Anti-Wrinkle Injections

Brow ptosis — the descent of one or both brows following botulinum toxin treatment — is one of the more distressing outcomes a patient can experience after an anti-wrinkle appointment. The brow feels heavy, the upper eyelid space appears crowded, and for many patients, particularly women, daily tasks like applying eye makeup become genuinely difficult. It is important to understand what is actually happening anatomically, why some patients are more susceptible than others, and — critically — that there is often something that can be done about it before the treatment naturally wears off.

Understanding the Anatomy: The Frontalis and Its Role

The frontalis is the primary elevator of the brow — it is the muscle that lifts your brows upward and creates horizontal forehead lines when contracted. It is also one of the most common targets of anti-wrinkle injections.¹ When botulinum toxin is placed into the frontalis, the goal is to soften those lines by reducing the muscle's contractile force. The challenge is that not all patients hold their brows up with the same degree of active muscle recruitment.

Some patients have strong, independent brow support — their brows sit comfortably at rest without much active frontalis engagement. In these patients, relaxing the frontalis produces smooth foreheads with brows that remain in a natural position. Others, however, rely on chronic low-level frontalis contraction simply to hold their brows where they want them. These patients have less passive brow support — anatomists sometimes refer to this as reduced frontalis reserve — and when their frontalis is substantially relaxed, the brow descends.²

Who Is Most at Risk

Brow ptosis from frontalis treatment is not random — it follows a predictable pattern based on patient anatomy. The patients most vulnerable are those with:

An experienced injector will identify these risk factors at consultation and adapt their technique accordingly — typically by treating the lower frontalis more conservatively, preserving some residual elevator action, and placing product higher in the muscle to allow natural brow support to be maintained.

Brow Ptosis vs Eyelid Ptosis: A Critical Distinction

These two terms sound similar and are often confused — but they are anatomically distinct, have different causes, and require different management.

Feature	Brow Ptosis	Eyelid Ptosis
Structure affected	The brow descends	The upper eyelid droops
Muscle involved	Frontalis (elevator) under-treated; or brow depressors relatively dominant	Levator palpebrae superioris — the muscle that lifts the eyelid itself4
Cause	Over-relaxation of frontalis; low baseline brow support	Product diffusion from glabella or forehead into the levator4
Appearance	Brow sits lower; forehead looks heavy; hooding over the lateral eye	Eyelid margin drops; eye appears smaller; asymmetric opening
Corrective injection?	Yes — orbicularis oculi injection can help	Apraclonidine eye drops (Iopidine) — stimulate Müller's muscle4
Resolution time	6–10 weeks typically	4–8 weeks typically4

It is worth noting that brow ptosis can secondarily cause the appearance of eyelid heaviness — when the brow descends, it pushes redundant skin over the eyelid, which can look very similar to eyelid ptosis at first glance. A careful clinical examination distinguishes the two: in true eyelid ptosis, the eyelid margin itself is low; in brow ptosis, the eyelid margin is normal but the brow-to-lid distance is reduced. This distinction matters because the management approaches are different.⁵

Can It Be Fixed? The Corrective Injection

This is the part most patients don't know: brow ptosis can often be meaningfully improved with a small corrective injection — without waiting for the original treatment to wear off.

The brow is held in position by a balance of elevators (frontalis) and depressors. The primary brow depressors include the corrugator supercilii, procerus, and importantly the lateral fibres of the orbicularis oculi — which pull the lateral brow downward and inward.⁶ When the frontalis has been substantially relaxed, these depressor muscles — which are still fully functional — become relatively dominant. The balance tips toward descent.

A small, precisely placed dose of botulinum toxin into the lateral orbicularis oculi — specifically the portion that acts as a brow depressor — can reduce the downward pull and allow the remaining frontalis activity to reassert some lift.^6,7 This technique does not reverse what has been done to the frontalis. Rather, it rebalances the opposing forces, giving the brow a better chance of recovering to a more natural resting position.

The injection is small in volume, placed carefully to avoid affecting eyelid function, and when correctly performed by a clinician who understands the anatomy, it can produce a noticeable improvement in brow position within 7–14 days.⁷

What Patients Notice Most: The Makeup Problem

Brow ptosis after anti-wrinkle injections is disproportionately distressing for female patients — and the reason is practical as much as aesthetic. When the brow descends, the skin of the upper eyelid is displaced downward, reducing the visible lid space. For patients accustomed to applying eyeshadow, eyeliner, or defining the brow with makeup, this change is immediately apparent and frustrating to work around.

The canvas effectively shrinks. Eyeshadow placement becomes difficult, liner sits in a different position, and the structural cues that makeup normally follows are altered. Many patients describe the experience as looking perpetually tired regardless of how much they sleep — a sentiment that is both accurate and understandable given what has happened to the brow architecture.³

This is clinically important information. It reinforces why careful patient assessment before treatment — and conservative initial dosing in higher-risk patients — is far preferable to managing the consequences afterward.

The Reassuring Baseline: It Always Wears Off

Even in cases where the corrective injection does not provide sufficient improvement, brow ptosis from botulinum toxin is temporary without exception. The neuromuscular blockade produced by botulinum toxin A reverses through a reliable process of axonal sprouting and synaptic remodelling — the nerve terminal generates new motor endplates that restore signalling to the muscle.⁸

For brow ptosis specifically, the timeline to natural resolution is typically 6–10 weeks, depending on the dose used and the individual's rate of metabolism.¹ In the worst case — a patient with significant descent who does not respond adequately to corrective injection — the absolute outer boundary of effect is the standard botulinum toxin treatment duration of three to six months. At that point, the frontalis recovers its full function and the brow returns to its baseline position.

This is not a small reassurance. Unlike a surgical procedure or a permanent filler, there is no scenario with botulinum toxin where the outcome is irreversible. The body's neuromuscular recovery is reliable, complete, and time-bounded.⁸

Prevention: What Good Assessment Looks Like

The most effective management of brow ptosis is avoiding it in the first place. At consultation, an experienced injector should assess brow position at rest and in animation, look for evidence of compensatory frontalis recruitment (brows visibly elevated relative to the orbital rim at rest), test the effect of manually relaxing the brow to the orbital rim, and factor in skin laxity, age, and brow weight.

In patients identified as higher risk, the appropriate response is not to refuse treatment — it is to adapt the approach. This typically means treating the lower forehead more conservatively, dosing the upper frontalis more modestly, preserving some muscle activity in the brow-level band of the frontalis, and setting accurate patient expectations before proceeding. A conservative first treatment with a planned review is always preferable to an aggressive treatment followed by a complication.

Summary

Brow ptosis following anti-wrinkle injections occurs when the frontalis — the brow's primary elevator — is relaxed in a patient who lacked sufficient passive brow support to begin with. It is most common in patients with low frontalis reserve, heavier brow tissue, or higher doses. It is not the same as eyelid ptosis, which involves the levator palpebrae and requires different management. When it does occur, a corrective injection into the lateral orbicularis oculi can often meaningfully improve brow position by rebalancing the elevator-depressor relationship. Even when correction is incomplete, the condition resolves fully within the standard treatment duration — three to six months at most. The goal, always, is to identify susceptible patients before treatment and calibrate the approach accordingly.